Updates on Diagnosis and Treatment for Pediatric Solid Tumors

A special issue of Current Oncology (ISSN 1718-7729). This special issue belongs to the section "Childhood, Adolescent and Young Adult Oncology".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 197

Special Issue Editor


E-Mail Website
Guest Editor
Department of Neurological Surgery, Indiana University School of Medicine, Indianapolis, IN 46202, USA
Interests: neurooncology; precision medicine; translational oncology

Special Issue Information

Dear Colleagues,

We are excited to invite you to contribute to our upcoming Special Issue in Current Oncology, titled “Updates on Diagnosis and Treatment for Pediatric Solid Tumors”. This Special Issue aims to bridge critical gaps in the current landscape of pediatric solid tumor research and treatment. Given your expertise, your contribution would be invaluable in enhancing our collective understanding and advancing the field.

Despite significant strides being made in pediatric oncology, challenges persist, particularly in developing precise diagnostic tools and treatments tailored to children's unique physiology. The complexity of tumor heterogeneity and its role in differential treatment responses adds another layer of intricacy. Furthermore, orphan diseases and rare tumors, often lacking standard care protocols, meaning that they present unique challenges. The long-term effects and survivorship issues are under-explored, and the psychosocial impact on patients and families often receives insufficient attention. Additionally, disparities in access to advanced treatments and the economic burden on families and healthcare systems underscore the urgent need for innovative research and comprehensive studies that address these multifaceted challenges.

To address these critical gaps, for this Special Issue, we welcome papers which focus on a range of topics, each providing a unique perspective and potential solutions:

  1. Emerging Diagnostic and Therapeutic Technologies: Advances in less invasive diagnostic methods and targeted treatments.
  2. Personalized Medicine and Pharmacogenomics: Tailoring treatments based on genetic profiles and individual responses to therapy.
  3. Targeted Therapy and Translational Medicine: Development of preclinical models for testing new therapies and translating research findings into clinical practice.
  4. Long-term Effects and Survivorship: Studies focusing on the after-effects of cancer treatment and strategies for long-term care.
  5. Psychosocial Impact: Research into the psychological, emotional, and social challenges faced by pediatric patients and their families.
  6. Economic and Access Disparities: Investigations into disparities in healthcare access and the economic impact of treatments.
  7. Multidisciplinary Care Approaches: Evaluations of the effectiveness of coordinated and comprehensive care models.
  8. Early Detection and Screening: Development of screening methods and early detection strategies for pediatric solid tumors.
  9. Clinical Trials and Emerging Treatments: Reports on new therapies and their transition from clinical trials to clinical practice.
  10. Epidemiology and Risk Factors: Insights into changing trends and new risk factors in pediatric solid tumors.
  11. Healthcare Policies in Pediatric Oncology: Analysis of policies affecting treatment access and healthcare delivery for pediatric cancer patients.

We encourage submissions of original research, reviews, case studies, highly novel case reports, retrospective studies, or perspectives that align with these themes. Your insights could help significantly shape future directions and improve outcomes for pediatric solid tumor patients.

Dr. Nur P. Damayanti
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Oncology is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • pediatric tumors
  • diagnostic innovation
  • targeted therapy
  • personalized oncology
  • pediatric pharmacogenomics
  • translational oncology
  • pediatric rare tumor
  • cancer survivorship
  • early detection
  • pediatric clinical trial

Published Papers

This special issue is now open for submission.
Back to TopTop